MetLife Investment Management’s NRC Health Common Stock NRC Stock Holding History

MetLife Investment Management’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$113K	Sell	6,673 -307	-4%	-$5.22K	﹤0.01%	2485
2025 Q4	$131K	Sell	6,980 -4,650	-40%	-$70.2K	﹤0.01%	2478
2025 Q3	$149K	Hold	11,630	–	–	﹤0.01%	2477
2025 Q2	$195K	Hold	11,630	–	–	﹤0.01%	2213
2025 Q1	$149K	Hold	11,630	–	–	﹤0.01%	2350
2024 Q4	$205K	Buy	11,630 +2,592	+29%	+$49.2K	﹤0.01%	2291
2024 Q3	$207K	Hold	9,038	–	–	﹤0.01%	2273
2024 Q2	$207K	Buy	9,038 +1,799	+25%	+$55.5K	﹤0.01%	2221
2024 Q1	$287K	Hold	7,239	–	–	﹤0.01%	1979
2023 Q4	$286K	Hold	7,239	–	–	﹤0.01%	2032
2023 Q3	$321K	Hold	7,239	–	–	﹤0.01%	1898
2023 Q2	$315K	Hold	7,239	–	–	﹤0.01%	1980
2023 Q1	$315K	Hold	7,239	–	–	﹤0.01%	1925
2022 Q4	$270K	Buy	7,239 +292	+4%	+$11.3K	﹤0.01%	2057
2022 Q3	$276K	Sell	6,947 -903	-12%	-$33.4K	﹤0.01%	2081
2022 Q2	$300K	Sell	7,850 -1,606	-17%	-$58.1K	﹤0.01%	2022
2022 Q1	$375K	Buy	9,456 +3,250	+52%	+$127K	﹤0.01%	1959
2021 Q4	$258K	Hold	6,206	–	–	﹤0.01%	1899
2021 Q3	$262K	Hold	6,206	–	–	﹤0.01%	1911
2021 Q2	$285K	Hold	6,206	–	–	﹤0.01%	1927
2021 Q1	$291K	Hold	6,206	–	–	﹤0.01%	1830
2020 Q4	$265K	Hold	6,206	–	–	﹤0.01%	1828
2020 Q3	$305K	Hold	6,206	–	–	﹤0.01%	1622
2020 Q2	$361K	Buy	6,206 +1,237	+25%	+$65.3K	﹤0.01%	1553
2020 Q1	$226K	Hold	4,969	–	–	﹤0.01%	1631
2019 Q4	$328K	Hold	4,969	–	–	﹤0.01%	1690
2019 Q3	$287K	Sell	4,969 -1,712	-26%	-$106K	﹤0.01%	1732
2019 Q2	$385K	Buy	6,681 +1,731	+35%	+$80.1K	﹤0.01%	1633
2019 Q1	$191K	Hold	4,950	–	–	﹤0.01%	2003
2018 Q4	$189K	Hold	4,950	–	–	﹤0.01%	1939
2018 Q3	$191K	Hold	4,950	–	–	﹤0.01%	2109
2018 Q2	$185K	Hold	4,950	–	–	﹤0.01%	1953
2018 Q1	$145K	Hold	4,950	–	–	﹤0.01%	2052
2017 Q4	$185K	Buy	+4,950	New	+$176K	﹤0.01%	1975

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.24B AUM 31.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

MetLife Investment Management's NRC Position: Q1 2026 in Review

MetLife Investment Management reduced its NRC Health Common Stock (NRC) stake by 4.4% in Q1 2026, selling an estimated $5.22K and leaving 6,673 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2485.

MetLife Investment Management first reported a position in NRC in Q4 2017 and has held it in 34 quarters since. The position peaked at $385K in Q2 2019. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

MetLife Investment Management held 6,673 shares of NRC Health Common Stock worth $113K as of Q1 2026.
MetLife Investment Management sold 307 NRC Health Common Stock shares in Q1 2026, an estimated $5.22K.
NRC Health Common Stock made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2485 holding.
MetLife Investment Management first reported a position in NRC Health Common Stock in Q4 2017 and has held it in 34 quarters since.
MetLife Investment Management's NRC Health Common Stock position peaked at $385K in Q2 2019.
121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.